Halliwell B, Cutteridge JMC: “Free radicals in biology and medicine.” Oxford: Oxford University Press, 1999.
1993, “Cytochrome P450.”, 3
1978, N Engl J Med, 298, 721, 10.1056/NEJM197803302981305
1983, “Radioprotectors and anticarcinogenes.”, 575
1993, Proc Natl Acad Sci USA, 90, 7915, 10.1073/pnas.90.17.7915
1991, Pharmac Rev, 43, 109
1996, Ann Rev Nutr, 20, 2261
2000, Lancet, 355, 1179, 10.1016/S0140-6736(00)02075-4
1980, Experientia, 20, 21
1994, Eur J Clin Invest, 24, 316, 10.1111/j.1365-2362.1994.tb01091.x
1997, Mol Cell Biochem, 166, 35, 10.1023/A:1006841228483
1994, Cancer, 73, 2013, 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J
1999, BioEssays, 21, 84, 10.1002/(SICI)1521-1878(199901)21:1<84::AID-BIES11>3.0.CO;2-0
1995, Bioch Biophys Acta, 1271, 59, 10.1016/0925-4439(95)00010-2
1996, Proc Natl Acad USA, 93, 11848, 10.1073/pnas.93.21.11848
1997, Immunol Today, 18, 44, 10.1016/S0167-5699(97)80014-X
1992, Cancer Metast Rev, 11, 121, 10.1007/BF00048059
1995, Biochem Pharmacol, 40, 1021
1996, Biochem Soc Trans, 24, 229, 10.1042/bst0240229
Salganik RI, Sivashinskiy MS, Lopaczinsky W, Gulij M, Veisman A, Bokovanov VE, Zeisel SH: Controlling the anticancer activity of cisplatin by changing the redox state of MCF-7 breast cancer cells. Carcinogenesis, in press, 2001.
Nickolloff JA, Hoekstra MF (eds): “DNA Damage and Repair,” vols. 1 and 2. Totova, New Jersey: Human Press, 1998.
2000, Carcinogenesis, 21, 909, 10.1093/carcin/21.5.909
1989, Free Rad Res Commun, 7, 94
1995, “Chemistry, Ecology, Health.”, 31
1994, Bioch Bophys Res Commun, 199, 726, 10.1006/bbrc.1994.1289
1994, Bioch Bophys Res Commun, 205, 180, 10.1006/bbrc.1994.2647
1996, Bioch Bophys Res Commun, 221, 300, 10.1006/bbrc.1996.0590
2001, J Anti-Aging Med, 4, 49, 10.1089/109454501750225686
1994, N Engl J Med, 330, 1029, 10.1056/NEJM199404143301501
1998, J Natl Cancer Inst, 90, 440, 10.1093/jnci/90.6.440
1996, N Engl J Med, 334, 1150, 10.1056/NEJM199605023341802
1995, Am J Clin Nutr, 52, 1377S
1996, Lancet, 347, 249, 10.1016/S0140-6736(96)90413-4
1999, Drug Safety, 4, 253
1993, J Natl Cancer Inst, 85, 1483, 10.1093/jnci/85.18.1483
1992, Ann Rev Nutr, 12, 139, 10.1146/annurev.nu.12.070192.001035
1993, Cancer Res, 53, 4230
1999, Cancer, 86, 1783, 10.1002/(SICI)1097-0142(19991101)86:9<1783::AID-CNCR21>3.0.CO;2-N
1994, Acta Oncol, 33, 615, 10.3109/02841869409121771
1995, Health Perspect, 103, 177, 10.1289/ehp.95103s6177
1994, Nutr Res Rev, 7, 1, 10.1079/NRR19940004
1999, Carcinogenesis, 20, 2261, 10.1093/carcin/20.12.2261
1999, Carcinogenesis, 20, 2267, 10.1093/carcin/20.12.2267
Dobzhansky T: “Genetic Diversity and Human Equality.” New York: Basic Books, Inc. Publishers, 1973.
Werner KM: “Genetic Variation and Human Disease.” Cambridge University Press, 1993.
1999, FEBS Lett, 445, 295, 10.1016/S0014-5793(99)00141-6
1999, Nutr Cancer, 35, 189, 10.1207/S15327914NC352_14
2001, FASEB J, 15, 403, 10.1096/fj.00-0251com
1997, Nature Med, 11, 1233
1992, J Am Coll Nutr, 11, 487, 10.1080/07315724.1992.10718253
1999, Nutr Cancer, 35, 189, 10.1207/S15327914NC352_14
